open access

Vol 82, No 6 (2011)
ARTICLES
Get Citation

Pro12Ala PPAR gamma2 gene polymorphism in women with polycystic ovary syndrome

Bożena Bidzińska-Speichert, Agnieszka Lenarcik, Urszula Tworowska-Bardzińska, Ryszard Ślęzak, Grażyna Bednarek-Tupikowska, Andrzej Milewicz, Katarzyna Krępuła
Ginekol Pol 2011;82(6).

open access

Vol 82, No 6 (2011)
ARTICLES

Abstract

Abstract Introduction: The pathogenesis of PCOS has not been definitively determined and includes a number of genes linked with steroidogenesis, regulation of gonadotropin secretion, actions of insulin, obesity, as well as chronic inflammatory processes. Some authors indicate that PPARγ play a role in insulin sensitivity and are probably involved in hyperandrogenism in PCOS. The aim of the study was to assess the frequency of the Pro12Ala and Pro115Gln PPARγ2 gene polymorphisms in women with PCOS. Subjects and methods: 54 PCOS women and 51 healthy women were recruited. Genetic studies to detect Pro12Ala and Pro115Gln PPARγ2 gene polymorphism were performed. Results: In the whole studied group the Pro115Gln polymorphism of the PPARγ2 gene was not found. The frequency of the Pro12Ala polymorphism was estimated at 26.47% in the controls and at 23.15% in the PCOS patients. Women from the control and PCOS groups with BMI ≥30 had statistically higher occurrence of the Ala allele than women with BMI <30 (38.80% versus 12.50% and 38.23% versus 18.75%). Conclusions: The frequency of the Pro12Ala polymorphism observed in the sample of women from the Lower Silesian population was significantly higher than in the majority of European populations.

Abstract

Abstract Introduction: The pathogenesis of PCOS has not been definitively determined and includes a number of genes linked with steroidogenesis, regulation of gonadotropin secretion, actions of insulin, obesity, as well as chronic inflammatory processes. Some authors indicate that PPARγ play a role in insulin sensitivity and are probably involved in hyperandrogenism in PCOS. The aim of the study was to assess the frequency of the Pro12Ala and Pro115Gln PPARγ2 gene polymorphisms in women with PCOS. Subjects and methods: 54 PCOS women and 51 healthy women were recruited. Genetic studies to detect Pro12Ala and Pro115Gln PPARγ2 gene polymorphism were performed. Results: In the whole studied group the Pro115Gln polymorphism of the PPARγ2 gene was not found. The frequency of the Pro12Ala polymorphism was estimated at 26.47% in the controls and at 23.15% in the PCOS patients. Women from the control and PCOS groups with BMI ≥30 had statistically higher occurrence of the Ala allele than women with BMI <30 (38.80% versus 12.50% and 38.23% versus 18.75%). Conclusions: The frequency of the Pro12Ala polymorphism observed in the sample of women from the Lower Silesian population was significantly higher than in the majority of European populations.
Get Citation

Keywords

polycystic ovary syndrome, Pro12Ala, Pro115Gln, PPARgamma2

About this article
Title

Pro12Ala PPAR gamma2 gene polymorphism in women with polycystic ovary syndrome

Journal

Ginekologia Polska

Issue

Vol 82, No 6 (2011)

Bibliographic record

Ginekol Pol 2011;82(6).

Keywords

polycystic ovary syndrome
Pro12Ala
Pro115Gln
PPARgamma2

Authors

Bożena Bidzińska-Speichert
Agnieszka Lenarcik
Urszula Tworowska-Bardzińska
Ryszard Ślęzak
Grażyna Bednarek-Tupikowska
Andrzej Milewicz
Katarzyna Krępuła

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl